Article By:
Zacks Investment Research
Saturday, April 18, 2015 12:16 PM EDT
We remind investors that Targacept is set to merge with Catalyst Biosciences, Inc., a privately held biopharmaceutical company. The combined company is expected to take up the name Catalyst Biosciences, Inc.
